Bio Green Med Solution, Inc. (NASDAQ: BGMS) Stock Competitors & Peer Comparison
See BGMS's competitors and their performance on the NASDAQ and across the wider stock market.
Peer Comparison Table: Medical - Pharmaceuticals Industry
Detailed financial metrics including price, market cap, P/E ratio, and more for BGMS and its NASDAQ peers.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| BGMS | $0.94 | +6.70% | 5.2M | -0.26 | -$3.56 | N/A |
| RPRX | $58.41 | -0.88% | 25.9B | 11.13 | $5.25 | +1.59% |
| CORT | $110.29 | -3.98% | 11.9B | 315.11 | $0.35 | N/A |
| WBA | $11.98 | +0.50% | 10.4B | -1.64 | -$7.29 | +4.17% |
| LQDA | $66.88 | -2.21% | 5.9B | 477.71 | $0.14 | N/A |
| KNSA | $77.24 | -2.63% | 5.9B | 85.82 | $0.90 | N/A |
| PBH | $44.97 | -3.23% | 2.1B | 10.17 | $4.42 | N/A |
| HROWL | $25.61 | +0.19% | 1.4B | N/A | N/A | N/A |
| LTGO | $22.55 | -5.77% | 1.4B | N/A | N/A | N/A |
| HROWM | $26.03 | -0.08% | 1.3B | N/A | N/A | N/A |
Stock Comparison
Royalty Pharma plc (NASDAQ: RPRX)
BGMS vs RPRX Comparison September 2026
Bio Green Med Solution, Inc. (NASDAQ: BGMS) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BGMS stands at 5.2M. In comparison, RPRX has a market cap of 25.9B. Regarding current trading prices, BGMS is priced at $0.94 on the NASDAQ, while RPRX trades at $58.41.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BGMS currently has a P/E ratio of -0.26, whereas RPRX's P/E ratio is 11.13. In terms of profitability, BGMS's ROE is -0.32%, compared to RPRX's ROE of +0.12%. Regarding short-term risk, BGMS is more volatile compared to RPRX. This indicates higher risk in terms of short-term price fluctuations for BGMS.Check RPRX's competition here
Corcept Therapeutics Incorporated (NASDAQ: CORT)
BGMS vs CORT Comparison September 2026
Bio Green Med Solution, Inc. (NASDAQ: BGMS) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BGMS stands at 5.2M. In comparison, CORT has a market cap of 11.9B. Regarding current trading prices, BGMS is priced at $0.94 on the NASDAQ, while CORT trades at $110.29.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BGMS currently has a P/E ratio of -0.26, whereas CORT's P/E ratio is 315.11. In terms of profitability, BGMS's ROE is -0.32%, compared to CORT's ROE of +0.08%. Regarding short-term risk, BGMS is less volatile compared to CORT. This indicates lower risk in terms of short-term price fluctuations for BGMS.Check CORT's competition here
Walgreens Boots Alliance, Inc. (NASDAQ: WBA)
BGMS vs WBA Comparison September 2026
Bio Green Med Solution, Inc. (NASDAQ: BGMS) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BGMS stands at 5.2M. In comparison, WBA has a market cap of 10.4B. Regarding current trading prices, BGMS is priced at $0.94 on the NASDAQ, while WBA trades at $11.98.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BGMS currently has a P/E ratio of -0.26, whereas WBA's P/E ratio is -1.64. In terms of profitability, BGMS's ROE is -0.32%, compared to WBA's ROE of -0.57%. Regarding short-term risk, BGMS is more volatile compared to WBA. This indicates higher risk in terms of short-term price fluctuations for BGMS.Check WBA's competition here
Liquidia Corporation (NASDAQ: LQDA)
BGMS vs LQDA Comparison September 2026
Bio Green Med Solution, Inc. (NASDAQ: BGMS) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BGMS stands at 5.2M. In comparison, LQDA has a market cap of 5.9B. Regarding current trading prices, BGMS is priced at $0.94 on the NASDAQ, while LQDA trades at $66.88.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BGMS currently has a P/E ratio of -0.26, whereas LQDA's P/E ratio is 477.71. In terms of profitability, BGMS's ROE is -0.32%, compared to LQDA's ROE of +1.50%. Regarding short-term risk, BGMS is more volatile compared to LQDA. This indicates higher risk in terms of short-term price fluctuations for BGMS.Check LQDA's competition here
Kiniksa Pharmaceuticals International, plc (NASDAQ: KNSA)
BGMS vs KNSA Comparison September 2026
Bio Green Med Solution, Inc. (NASDAQ: BGMS) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BGMS stands at 5.2M. In comparison, KNSA has a market cap of 5.9B. Regarding current trading prices, BGMS is priced at $0.94 on the NASDAQ, while KNSA trades at $77.24.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BGMS currently has a P/E ratio of -0.26, whereas KNSA's P/E ratio is 85.82. In terms of profitability, BGMS's ROE is -0.32%, compared to KNSA's ROE of +0.14%. Regarding short-term risk, BGMS is more volatile compared to KNSA. This indicates higher risk in terms of short-term price fluctuations for BGMS.Check KNSA's competition here
Prestige Consumer Healthcare Inc. (NYSE: PBH)
BGMS vs PBH Comparison September 2026
Bio Green Med Solution, Inc. (NASDAQ: BGMS) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BGMS stands at 5.2M. In comparison, PBH has a market cap of 2.1B. Regarding current trading prices, BGMS is priced at $0.94 on the NASDAQ, while PBH trades at $44.97.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BGMS currently has a P/E ratio of -0.26, whereas PBH's P/E ratio is 10.17. In terms of profitability, BGMS's ROE is -0.32%, compared to PBH's ROE of +0.09%. Regarding short-term risk, BGMS is more volatile compared to PBH. This indicates higher risk in terms of short-term price fluctuations for BGMS.Check PBH's competition here
Harrow Health, Inc. 8.625% Senior Notes due 2026 (NASDAQ: HROWL)
BGMS vs HROWL Comparison September 2026
Bio Green Med Solution, Inc. (NASDAQ: BGMS) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BGMS stands at 5.2M. In comparison, HROWL has a market cap of 1.4B. Regarding current trading prices, BGMS is priced at $0.94 on the NASDAQ, while HROWL trades at $25.61.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BGMS currently has a P/E ratio of -0.26, whereas HROWL's P/E ratio is N/A. In terms of profitability, BGMS's ROE is -0.32%, compared to HROWL's ROE of -1.04%. Regarding short-term risk, BGMS is more volatile compared to HROWL. This indicates higher risk in terms of short-term price fluctuations for BGMS.Check HROWL's competition here
Latigo Biotherapeutics Inc. (NASDAQ: LTGO)
BGMS vs LTGO Comparison September 2026
Bio Green Med Solution, Inc. (NASDAQ: BGMS) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BGMS stands at 5.2M. In comparison, LTGO has a market cap of 1.4B. Regarding current trading prices, BGMS is priced at $0.94 on the NASDAQ, while LTGO trades at $22.55.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BGMS currently has a P/E ratio of -0.26, whereas LTGO's P/E ratio is N/A. In terms of profitability, BGMS's ROE is -0.32%, compared to LTGO's ROE of N/A. Regarding short-term risk, BGMS is less volatile compared to LTGO. This indicates lower risk in terms of short-term price fluctuations for BGMS.Check LTGO's competition here
Harrow Health, Inc. 11.875% Senior Notes due 2027 (NASDAQ: HROWM)
BGMS vs HROWM Comparison September 2026
Bio Green Med Solution, Inc. (NASDAQ: BGMS) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BGMS stands at 5.2M. In comparison, HROWM has a market cap of 1.3B. Regarding current trading prices, BGMS is priced at $0.94 on the NASDAQ, while HROWM trades at $26.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BGMS currently has a P/E ratio of -0.26, whereas HROWM's P/E ratio is N/A. In terms of profitability, BGMS's ROE is -0.32%, compared to HROWM's ROE of -1.04%. Regarding short-term risk, BGMS is more volatile compared to HROWM. This indicates higher risk in terms of short-term price fluctuations for BGMS.Check HROWM's competition here
Cybin Inc. Common Stock (NASDAQ: HELP)
BGMS vs HELP Comparison September 2026
Bio Green Med Solution, Inc. (NASDAQ: BGMS) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BGMS stands at 5.2M. In comparison, HELP has a market cap of 766.7M. Regarding current trading prices, BGMS is priced at $0.94 on the NASDAQ, while HELP trades at $12.37.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BGMS currently has a P/E ratio of -0.26, whereas HELP's P/E ratio is -2.97. In terms of profitability, BGMS's ROE is -0.32%, compared to HELP's ROE of -0.71%. Regarding short-term risk, BGMS is less volatile compared to HELP. This indicates lower risk in terms of short-term price fluctuations for BGMS.Check HELP's competition here
Sinovac Biotech Ltd. (NASDAQ: SVA)
BGMS vs SVA Comparison September 2026
Bio Green Med Solution, Inc. (NASDAQ: BGMS) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BGMS stands at 5.2M. In comparison, SVA has a market cap of 464.9M. Regarding current trading prices, BGMS is priced at $0.94 on the NASDAQ, while SVA trades at $6.47.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BGMS currently has a P/E ratio of -0.26, whereas SVA's P/E ratio is -5.68. In terms of profitability, BGMS's ROE is -0.32%, compared to SVA's ROE of -0.01%. Regarding short-term risk, BGMS is more volatile compared to SVA. This indicates higher risk in terms of short-term price fluctuations for BGMS.Check SVA's competition here
Clinuvel Pharmaceuticals Ltd. (NASDAQ: CUVL)
BGMS vs CUVL Comparison September 2026
Bio Green Med Solution, Inc. (NASDAQ: BGMS) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BGMS stands at 5.2M. In comparison, CUVL has a market cap of 297.5M. Regarding current trading prices, BGMS is priced at $0.94 on the NASDAQ, while CUVL trades at $5.90.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BGMS currently has a P/E ratio of -0.26, whereas CUVL's P/E ratio is N/A. In terms of profitability, BGMS's ROE is -0.32%, compared to CUVL's ROE of N/A. Regarding short-term risk, BGMS is more volatile compared to CUVL. This indicates higher risk in terms of short-term price fluctuations for BGMS.Check CUVL's competition here
Bristol-Myers Squibb Company Ce (NYSE: CELG-RI)
BGMS vs CELG-RI Comparison September 2026
Bio Green Med Solution, Inc. (NASDAQ: BGMS) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BGMS stands at 5.2M. In comparison, CELG-RI has a market cap of 242.7M. Regarding current trading prices, BGMS is priced at $0.94 on the NASDAQ, while CELG-RI trades at $0.12.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BGMS currently has a P/E ratio of -0.26, whereas CELG-RI's P/E ratio is N/A. In terms of profitability, BGMS's ROE is -0.32%, compared to CELG-RI's ROE of N/A. Regarding short-term risk, BGMS is more volatile compared to CELG-RI. This indicates higher risk in terms of short-term price fluctuations for BGMS.Check CELG-RI's competition here
High Tide Inc. (NASDAQ: HITI)
BGMS vs HITI Comparison September 2026
Bio Green Med Solution, Inc. (NASDAQ: BGMS) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BGMS stands at 5.2M. In comparison, HITI has a market cap of 226.7M. Regarding current trading prices, BGMS is priced at $0.94 on the NASDAQ, while HITI trades at $2.58.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BGMS currently has a P/E ratio of -0.26, whereas HITI's P/E ratio is -7.57. In terms of profitability, BGMS's ROE is -0.32%, compared to HITI's ROE of -0.36%. Regarding short-term risk, BGMS is more volatile compared to HITI. This indicates higher risk in terms of short-term price fluctuations for BGMS.Check HITI's competition here
Citius Oncology, Inc. (NASDAQ: CTOR)
BGMS vs CTOR Comparison September 2026
Bio Green Med Solution, Inc. (NASDAQ: BGMS) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BGMS stands at 5.2M. In comparison, CTOR has a market cap of 106M. Regarding current trading prices, BGMS is priced at $0.94 on the NASDAQ, while CTOR trades at $1.14.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BGMS currently has a P/E ratio of -0.26, whereas CTOR's P/E ratio is -2.43. In terms of profitability, BGMS's ROE is -0.32%, compared to CTOR's ROE of -1.03%. Regarding short-term risk, BGMS is less volatile compared to CTOR. This indicates lower risk in terms of short-term price fluctuations for BGMS.Check CTOR's competition here
Atlantic International Corp. (NASDAQ: ATLN)
BGMS vs ATLN Comparison September 2026
Bio Green Med Solution, Inc. (NASDAQ: BGMS) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BGMS stands at 5.2M. In comparison, ATLN has a market cap of 73.2M. Regarding current trading prices, BGMS is priced at $0.94 on the NASDAQ, while ATLN trades at $0.90.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BGMS currently has a P/E ratio of -0.26, whereas ATLN's P/E ratio is -0.68. In terms of profitability, BGMS's ROE is -0.32%, compared to ATLN's ROE of -83.20%. Regarding short-term risk, BGMS is less volatile compared to ATLN. This indicates lower risk in terms of short-term price fluctuations for BGMS.Check ATLN's competition here
Stablecoin Development Corp. (AMEX: SDEV)
BGMS vs SDEV Comparison September 2026
Bio Green Med Solution, Inc. (NASDAQ: BGMS) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BGMS stands at 5.2M. In comparison, SDEV has a market cap of 52.2M. Regarding current trading prices, BGMS is priced at $0.94 on the NASDAQ, while SDEV trades at $1.04.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BGMS currently has a P/E ratio of -0.26, whereas SDEV's P/E ratio is -0.18. In terms of profitability, BGMS's ROE is -0.32%, compared to SDEV's ROE of +7.90%. Regarding short-term risk, BGMS is less volatile compared to SDEV. This indicates lower risk in terms of short-term price fluctuations for BGMS.Check SDEV's competition here
Rite Aid Corporation (NYSE: RAD)
BGMS vs RAD Comparison September 2026
Bio Green Med Solution, Inc. (NASDAQ: BGMS) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BGMS stands at 5.2M. In comparison, RAD has a market cap of 36.8M. Regarding current trading prices, BGMS is priced at $0.94 on the NASDAQ, while RAD trades at $0.65.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BGMS currently has a P/E ratio of -0.26, whereas RAD's P/E ratio is -0.05. In terms of profitability, BGMS's ROE is -0.32%, compared to RAD's ROE of +2.76%. Regarding short-term risk, BGMS is less volatile compared to RAD. This indicates lower risk in terms of short-term price fluctuations for BGMS.Check RAD's competition here
Damora Therapeutics, Inc. (NASDAQ: GLTO)
BGMS vs GLTO Comparison September 2026
Bio Green Med Solution, Inc. (NASDAQ: BGMS) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BGMS stands at 5.2M. In comparison, GLTO has a market cap of 34.5M. Regarding current trading prices, BGMS is priced at $0.94 on the NASDAQ, while GLTO trades at $21.58.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BGMS currently has a P/E ratio of -0.26, whereas GLTO's P/E ratio is -1.78. In terms of profitability, BGMS's ROE is -0.32%, compared to GLTO's ROE of -0.83%. Regarding short-term risk, BGMS is less volatile compared to GLTO. This indicates lower risk in terms of short-term price fluctuations for BGMS.Check GLTO's competition here
Nasus Pharma Ltd. (AMEX: NSRX)
BGMS vs NSRX Comparison September 2026
Bio Green Med Solution, Inc. (NASDAQ: BGMS) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BGMS stands at 5.2M. In comparison, NSRX has a market cap of 29.7M. Regarding current trading prices, BGMS is priced at $0.94 on the NASDAQ, while NSRX trades at $3.53.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BGMS currently has a P/E ratio of -0.26, whereas NSRX's P/E ratio is -4.78. In terms of profitability, BGMS's ROE is -0.32%, compared to NSRX's ROE of -1.59%. Regarding short-term risk, BGMS is more volatile compared to NSRX. This indicates higher risk in terms of short-term price fluctuations for BGMS.Check NSRX's competition here
SCYNEXIS, Inc. (NASDAQ: SCYX)
BGMS vs SCYX Comparison September 2026
Bio Green Med Solution, Inc. (NASDAQ: BGMS) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BGMS stands at 5.2M. In comparison, SCYX has a market cap of 28M. Regarding current trading prices, BGMS is priced at $0.94 on the NASDAQ, while SCYX trades at $4.46.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BGMS currently has a P/E ratio of -0.26, whereas SCYX's P/E ratio is -1.30. In terms of profitability, BGMS's ROE is -0.32%, compared to SCYX's ROE of -0.21%. Regarding short-term risk, BGMS is more volatile compared to SCYX. This indicates higher risk in terms of short-term price fluctuations for BGMS.Check SCYX's competition here
Cosmos Health Inc. (NASDAQ: COSM)
BGMS vs COSM Comparison September 2026
Bio Green Med Solution, Inc. (NASDAQ: BGMS) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BGMS stands at 5.2M. In comparison, COSM has a market cap of 17.9M. Regarding current trading prices, BGMS is priced at $0.94 on the NASDAQ, while COSM trades at $0.32.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BGMS currently has a P/E ratio of -0.26, whereas COSM's P/E ratio is -0.45. In terms of profitability, BGMS's ROE is -0.32%, compared to COSM's ROE of -1.19%. Regarding short-term risk, BGMS is less volatile compared to COSM. This indicates lower risk in terms of short-term price fluctuations for BGMS.Check COSM's competition here
Biofrontera Inc. (NASDAQ: BFRI)
BGMS vs BFRI Comparison September 2026
Bio Green Med Solution, Inc. (NASDAQ: BGMS) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BGMS stands at 5.2M. In comparison, BFRI has a market cap of 16.9M. Regarding current trading prices, BGMS is priced at $0.94 on the NASDAQ, while BFRI trades at $1.32.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BGMS currently has a P/E ratio of -0.26, whereas BFRI's P/E ratio is -2.40. In terms of profitability, BGMS's ROE is -0.32%, compared to BFRI's ROE of -1.28%. Regarding short-term risk, BGMS is more volatile compared to BFRI. This indicates higher risk in terms of short-term price fluctuations for BGMS.Check BFRI's competition here
Cerenome, Inc. (NASDAQ: CNSY)
BGMS vs CNSY Comparison September 2026
Bio Green Med Solution, Inc. (NASDAQ: BGMS) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BGMS stands at 5.2M. In comparison, CNSY has a market cap of 14M. Regarding current trading prices, BGMS is priced at $0.94 on the NASDAQ, while CNSY trades at $2.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BGMS currently has a P/E ratio of -0.26, whereas CNSY's P/E ratio is -0.48. In terms of profitability, BGMS's ROE is -0.32%, compared to CNSY's ROE of -3.94%. Regarding short-term risk, BGMS is more volatile compared to CNSY. This indicates higher risk in terms of short-term price fluctuations for BGMS.Check CNSY's competition here
Scienture Holdings, Inc. (NASDAQ: SCNX)
BGMS vs SCNX Comparison September 2026
Bio Green Med Solution, Inc. (NASDAQ: BGMS) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BGMS stands at 5.2M. In comparison, SCNX has a market cap of 12.7M. Regarding current trading prices, BGMS is priced at $0.94 on the NASDAQ, while SCNX trades at $0.31.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BGMS currently has a P/E ratio of -0.26, whereas SCNX's P/E ratio is -0.15. In terms of profitability, BGMS's ROE is -0.32%, compared to SCNX's ROE of -0.54%. Regarding short-term risk, BGMS is more volatile compared to SCNX. This indicates higher risk in terms of short-term price fluctuations for BGMS.Check SCNX's competition here
Biofrontera Inc. (NASDAQ: BFRIW)
BGMS vs BFRIW Comparison September 2026
Bio Green Med Solution, Inc. (NASDAQ: BGMS) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BGMS stands at 5.2M. In comparison, BFRIW has a market cap of 11.4M. Regarding current trading prices, BGMS is priced at $0.94 on the NASDAQ, while BFRIW trades at $0.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BGMS currently has a P/E ratio of -0.26, whereas BFRIW's P/E ratio is -0.03. In terms of profitability, BGMS's ROE is -0.32%, compared to BFRIW's ROE of -1.28%. Regarding short-term risk, BGMS is more volatile compared to BFRIW. This indicates higher risk in terms of short-term price fluctuations for BGMS.Check BFRIW's competition here
China Jo-Jo Drugstores, Inc. (NASDAQ: CJJD)
BGMS vs CJJD Comparison September 2026
Bio Green Med Solution, Inc. (NASDAQ: BGMS) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BGMS stands at 5.2M. In comparison, CJJD has a market cap of 9.9M. Regarding current trading prices, BGMS is priced at $0.94 on the NASDAQ, while CJJD trades at $1.52.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BGMS currently has a P/E ratio of -0.26, whereas CJJD's P/E ratio is -0.46. In terms of profitability, BGMS's ROE is -0.32%, compared to CJJD's ROE of -0.25%. Regarding short-term risk, BGMS is more volatile compared to CJJD. This indicates higher risk in terms of short-term price fluctuations for BGMS.Check CJJD's competition here
SunLink Health Systems, Inc. (AMEX: SSY)
BGMS vs SSY Comparison September 2026
Bio Green Med Solution, Inc. (NASDAQ: BGMS) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BGMS stands at 5.2M. In comparison, SSY has a market cap of 7.9M. Regarding current trading prices, BGMS is priced at $0.94 on the NASDAQ, while SSY trades at $1.12.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BGMS currently has a P/E ratio of -0.26, whereas SSY's P/E ratio is -2.86. In terms of profitability, BGMS's ROE is -0.32%, compared to SSY's ROE of -0.09%. Regarding short-term risk, BGMS is less volatile compared to SSY. This indicates lower risk in terms of short-term price fluctuations for BGMS.Check SSY's competition here
POMDOCTOR Ltd (NASDAQ: POM)
BGMS vs POM Comparison September 2026
Bio Green Med Solution, Inc. (NASDAQ: BGMS) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BGMS stands at 5.2M. In comparison, POM has a market cap of 5.4M. Regarding current trading prices, BGMS is priced at $0.94 on the NASDAQ, while POM trades at $0.80.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BGMS currently has a P/E ratio of -0.26, whereas POM's P/E ratio is -0.16. In terms of profitability, BGMS's ROE is -0.32%, compared to POM's ROE of +0.16%. Regarding short-term risk, BGMS is less volatile compared to POM. This indicates lower risk in terms of short-term price fluctuations for BGMS.Check POM's competition here
Paranovus Entertainment Technology Ltd. (NASDAQ: PAVS)
BGMS vs PAVS Comparison September 2026
Bio Green Med Solution, Inc. (NASDAQ: BGMS) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BGMS stands at 5.2M. In comparison, PAVS has a market cap of 3.5M. Regarding current trading prices, BGMS is priced at $0.94 on the NASDAQ, while PAVS trades at $4.07.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BGMS currently has a P/E ratio of -0.26, whereas PAVS's P/E ratio is -0.05. In terms of profitability, BGMS's ROE is -0.32%, compared to PAVS's ROE of -0.46%. Regarding short-term risk, BGMS is more volatile compared to PAVS. This indicates higher risk in terms of short-term price fluctuations for BGMS.Check PAVS's competition here
Eocene Ltd. (NASDAQ: EOCN)
BGMS vs EOCN Comparison September 2026
Bio Green Med Solution, Inc. (NASDAQ: BGMS) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BGMS stands at 5.2M. In comparison, EOCN has a market cap of 3.5M. Regarding current trading prices, BGMS is priced at $0.94 on the NASDAQ, while EOCN trades at $3.37.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BGMS currently has a P/E ratio of -0.26, whereas EOCN's P/E ratio is -0.24. In terms of profitability, BGMS's ROE is -0.32%, compared to EOCN's ROE of N/A. Regarding short-term risk, BGMS is more volatile compared to EOCN. This indicates higher risk in terms of short-term price fluctuations for BGMS.Check EOCN's competition here
MedAvail Holdings, Inc. (NASDAQ: MDVL)
BGMS vs MDVL Comparison September 2026
Bio Green Med Solution, Inc. (NASDAQ: BGMS) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BGMS stands at 5.2M. In comparison, MDVL has a market cap of 2.9M. Regarding current trading prices, BGMS is priced at $0.94 on the NASDAQ, while MDVL trades at $1.80.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BGMS currently has a P/E ratio of -0.26, whereas MDVL's P/E ratio is -0.05. In terms of profitability, BGMS's ROE is -0.32%, compared to MDVL's ROE of -2.39%. Regarding short-term risk, BGMS is less volatile compared to MDVL. This indicates lower risk in terms of short-term price fluctuations for BGMS.Check MDVL's competition here
ETHZilla Corporation Warrant (NASDAQ: ATNFW)
BGMS vs ATNFW Comparison September 2026
Bio Green Med Solution, Inc. (NASDAQ: BGMS) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BGMS stands at 5.2M. In comparison, ATNFW has a market cap of 2.6M. Regarding current trading prices, BGMS is priced at $0.94 on the NASDAQ, while ATNFW trades at $0.43.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BGMS currently has a P/E ratio of -0.26, whereas ATNFW's P/E ratio is N/A. In terms of profitability, BGMS's ROE is -0.32%, compared to ATNFW's ROE of -2.15%. Regarding short-term risk, BGMS is less volatile compared to ATNFW. This indicates lower risk in terms of short-term price fluctuations for BGMS.Check ATNFW's competition here
Bio Green Med Solution, Inc. (NASDAQ: BGMSP)
BGMS vs BGMSP Comparison September 2026
Bio Green Med Solution, Inc. (NASDAQ: BGMS) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BGMS stands at 5.2M. In comparison, BGMSP has a market cap of 2.4M. Regarding current trading prices, BGMS is priced at $0.94 on the NASDAQ, while BGMSP trades at $1.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BGMS currently has a P/E ratio of -0.26, whereas BGMSP's P/E ratio is -0.84. In terms of profitability, BGMS's ROE is -0.32%, compared to BGMSP's ROE of -0.32%. Regarding short-term risk, BGMS is more volatile compared to BGMSP. This indicates higher risk in terms of short-term price fluctuations for BGMS.Check BGMSP's competition here
AstraZeneca PLC ADRhedged (AMEX: AZNH)
BGMS vs AZNH Comparison September 2026
Bio Green Med Solution, Inc. (NASDAQ: BGMS) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BGMS stands at 5.2M. In comparison, AZNH has a market cap of 1.6M. Regarding current trading prices, BGMS is priced at $0.94 on the NASDAQ, while AZNH trades at $53.74.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BGMS currently has a P/E ratio of -0.26, whereas AZNH's P/E ratio is 38.35. In terms of profitability, BGMS's ROE is -0.32%, compared to AZNH's ROE of +0.00%. Regarding short-term risk, BGMS is more volatile compared to AZNH. This indicates higher risk in terms of short-term price fluctuations for BGMS.Check AZNH's competition here
Leafly Holdings, Inc. (NASDAQ: LFLYW)
BGMS vs LFLYW Comparison September 2026
Bio Green Med Solution, Inc. (NASDAQ: BGMS) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BGMS stands at 5.2M. In comparison, LFLYW has a market cap of 299.9K. Regarding current trading prices, BGMS is priced at $0.94 on the NASDAQ, while LFLYW trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BGMS currently has a P/E ratio of -0.26, whereas LFLYW's P/E ratio is -0.00. In terms of profitability, BGMS's ROE is -0.32%, compared to LFLYW's ROE of +0.42%. Regarding short-term risk, BGMS is more volatile compared to LFLYW. This indicates higher risk in terms of short-term price fluctuations for BGMS.Check LFLYW's competition here
ProPhase Labs, Inc. (NASDAQ: PRPH)
BGMS vs PRPH Comparison September 2026
Bio Green Med Solution, Inc. (NASDAQ: BGMS) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BGMS stands at 5.2M. In comparison, PRPH has a market cap of 175.2K. Regarding current trading prices, BGMS is priced at $0.94 on the NASDAQ, while PRPH trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BGMS currently has a P/E ratio of -0.26, whereas PRPH's P/E ratio is N/A. In terms of profitability, BGMS's ROE is -0.32%, compared to PRPH's ROE of -13.59%. Regarding short-term risk, BGMS is less volatile compared to PRPH. This indicates lower risk in terms of short-term price fluctuations for BGMS.Check PRPH's competition here
Shire plc (NASDAQ: SHPG)
BGMS vs SHPG Comparison September 2026
Bio Green Med Solution, Inc. (NASDAQ: BGMS) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BGMS stands at 5.2M. In comparison, SHPG has a market cap of 0. Regarding current trading prices, BGMS is priced at $0.94 on the NASDAQ, while SHPG trades at $179.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BGMS currently has a P/E ratio of -0.26, whereas SHPG's P/E ratio is 11.35. In terms of profitability, BGMS's ROE is -0.32%, compared to SHPG's ROE of +0.13%. Regarding short-term risk, BGMS is more volatile compared to SHPG. This indicates higher risk in terms of short-term price fluctuations for BGMS.Check SHPG's competition here
Orexigen Therapeutics, Inc. (NASDAQ: OREX)
BGMS vs OREX Comparison September 2026
Bio Green Med Solution, Inc. (NASDAQ: BGMS) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BGMS stands at 5.2M. In comparison, OREX has a market cap of 0. Regarding current trading prices, BGMS is priced at $0.94 on the NASDAQ, while OREX trades at $0.22.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BGMS currently has a P/E ratio of -0.26, whereas OREX's P/E ratio is -0.14. In terms of profitability, BGMS's ROE is -0.32%, compared to OREX's ROE of -0.54%. Regarding short-term risk, BGMS is less volatile compared to OREX. This indicates lower risk in terms of short-term price fluctuations for BGMS.Check OREX's competition here
Impax Laboratories, Inc. (NASDAQ: IPXL)
BGMS vs IPXL Comparison September 2026
Bio Green Med Solution, Inc. (NASDAQ: BGMS) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BGMS stands at 5.2M. In comparison, IPXL has a market cap of 0. Regarding current trading prices, BGMS is priced at $0.94 on the NASDAQ, while IPXL trades at $18.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BGMS currently has a P/E ratio of -0.26, whereas IPXL's P/E ratio is -10.11. In terms of profitability, BGMS's ROE is -0.32%, compared to IPXL's ROE of -1.16%. Regarding short-term risk, BGMS is less volatile compared to IPXL. This indicates lower risk in terms of short-term price fluctuations for BGMS.Check IPXL's competition here
POZEN Inc. (NASDAQ: POZN)
BGMS vs POZN Comparison September 2026
Bio Green Med Solution, Inc. (NASDAQ: BGMS) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BGMS stands at 5.2M. In comparison, POZN has a market cap of 0. Regarding current trading prices, BGMS is priced at $0.94 on the NASDAQ, while POZN trades at $5.94.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BGMS currently has a P/E ratio of -0.26, whereas POZN's P/E ratio is N/A. In terms of profitability, BGMS's ROE is -0.32%, compared to POZN's ROE of +0.61%. Regarding short-term risk, BGMS is less volatile compared to POZN. This indicates lower risk in terms of short-term price fluctuations for BGMS.Check POZN's competition here
Express Scripts Holding Company (NASDAQ: ESRX)
BGMS vs ESRX Comparison September 2026
Bio Green Med Solution, Inc. (NASDAQ: BGMS) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BGMS stands at 5.2M. In comparison, ESRX has a market cap of 0. Regarding current trading prices, BGMS is priced at $0.94 on the NASDAQ, while ESRX trades at $92.33.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BGMS currently has a P/E ratio of -0.26, whereas ESRX's P/E ratio is 10.69. In terms of profitability, BGMS's ROE is -0.32%, compared to ESRX's ROE of +0.26%. Regarding short-term risk, BGMS is more volatile compared to ESRX. This indicates higher risk in terms of short-term price fluctuations for BGMS.Check ESRX's competition here
Caraco Pharmaceutical Laboratories Ltd (AMEX: CPD)
BGMS vs CPD Comparison September 2026
Bio Green Med Solution, Inc. (NASDAQ: BGMS) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BGMS stands at 5.2M. In comparison, CPD has a market cap of 0. Regarding current trading prices, BGMS is priced at $0.94 on the NASDAQ, while CPD trades at $5.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BGMS currently has a P/E ratio of -0.26, whereas CPD's P/E ratio is N/A. In terms of profitability, BGMS's ROE is -0.32%, compared to CPD's ROE of N/A. Regarding short-term risk, BGMS is more volatile compared to CPD. This indicates higher risk in terms of short-term price fluctuations for BGMS.Check CPD's competition here